Genetic Basis of Inhibitor Development in Severe Haemophilia A and B

This publication has 32 references indexed in Scilit:

• Incidence of inhibitors in haemophilia A patients – a review of recent studies of recombinant and plasma‐derived factor VIII concentrates
  Haemophilia, 1999
• The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4
  Nucleic Acids Research, 1998
• Haemophilia B: database of point mutations and short additions and deletions--eighth edition
  Nucleic Acids Research, 1998
• Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII
  Seminars in Thrombosis and Hemostasis, 1995
• Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII
  Journal of Biological Chemistry, 1995
• Gene Mutations and Inhibitor Formation in Patients with Hemophilia B
  Acta Haematologica, 1995
• Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
  The Journal of Experimental Medicine, 1993
• Characterization of a factor VIII immunogenic site using factor VIII synthetic peptide 1687–1695 and rabbit anti-peptide antibodies
  Thrombosis Research, 1992
• Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies
  British Journal of Haematology, 1990
• A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chain
  Blood Coagulation & Fibrinolysis, 1990